Allianz Asset Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $610K | Buy |
59,859
+7,000
| +13% | +$75.5K | ﹤0.01% | 1817 |
|
|
2025
Q4 | $565K | Hold |
52,859
| – | – | ﹤0.01% | 1819 |
|
|
2025
Q3 | $723K | Buy |
52,859
+31,017
| +142% | +$433K | ﹤0.01% | 1778 |
|
|
2025
Q2 | $307K | Buy |
+21,842
| New | +$287K | ﹤0.01% | 1905 |
|
|
2023
Q3 | – | Sell |
-12,837
| Closed | -$1.18M | – | 2233 |
|
|
2023
Q2 | $1.18M | Sell |
12,837
-28,771
| -69% | -$2.56M | ﹤0.01% | 1479 |
|
|
2023
Q1 | $4.31M | Buy |
41,608
+5,509
| +15% | +$611K | 0.01% | 1035 |
|
|
2022
Q4 | $4.16M | Sell |
36,099
-37,803
| -51% | -$4.4M | 0.01% | 996 |
|
|
2022
Q3 | $8.01M | Sell |
73,902
-11,934
| -14% | -$1.71M | 0.02% | 730 |
|
|
2022
Q2 | $15.5M | Buy |
85,836
+4,131
| +5% | +$739K | 0.01% | 755 |
|
|
2022
Q1 | $14M | Sell |
81,705
-23,452
| -22% | -$4.42M | 0.01% | 878 |
|
|
2021
Q4 | $22.1M | Sell |
105,157
-14,818
| -12% | -$3.06M | 0.02% | 735 |
|
|
2021
Q3 | $23.1M | Buy |
119,975
+23,526
| +24% | +$5.78M | 0.02% | 681 |
|
|
2021
Q2 | $27.3M | Buy |
96,449
+47,057
| +95% | +$12.8M | 0.02% | 536 |
|
|
2021
Q1 | $10.5M | Buy |
49,392
+606
| +1% | +$145K | 0.01% | 821 |
|
|
2020
Q4 | $9.58M | Buy |
48,786
+42,042
| +623% | +$7.43M | 0.01% | 853 |
|
|
2020
Q3 | $1.11M | Buy |
6,744
+1,847
| +38% | +$304K | ﹤0.01% | 1401 |
|
|
2020
Q2 | $680K | Buy |
+4,897
| New | +$450K | ﹤0.01% | 1957 |
|
|
2020
Q1 | – | Sell |
-9,336
| Closed | -$1.02M | – | 2649 |
|
|
2019
Q4 | $1.02M | Sell |
9,336
-13,615
| -59% | -$1.32M | ﹤0.01% | 2184 |
|
|
2019
Q3 | $2.38M | Sell |
22,951
-124,513
| -84% | -$13.4M | ﹤0.01% | 1764 |
|
|
2019
Q2 | $18.9M | Buy |
147,464
+37,293
| +34% | +$5.18M | 0.02% | 836 |
|
|
2019
Q1 | $14.1M | Buy |
110,171
+5,270
| +5% | +$668K | 0.01% | 938 |
|
|
2018
Q4 | $13.1M | Buy |
104,901
+23,590
| +29% | +$4.04M | 0.01% | 970 |
|
|
2018
Q3 | $18M | Sell |
81,311
-5,084
| -6% | -$1.03M | 0.02% | 954 |
|
|
2018
Q2 | $13.8M | Buy |
86,395
+35,168
| +69% | +$4.5M | 0.01% | 1092 |
|
|
2018
Q1 | $4.79M | Buy |
51,227
+35,124
| +218% | +$2.62M | ﹤0.01% | 1551 |
|
|
2017
Q4 | $1.12M | Sell |
16,103
-2,904
| -15% | -$193K | ﹤0.01% | 2206 |
|
|
2017
Q3 | $1.13M | Sell |
19,007
-74,230
| -80% | -$3.69M | ﹤0.01% | 2205 |
|
|
2017
Q2 | $3.86M | Buy |
93,237
+57,997
| +165% | +$2.52M | ﹤0.01% | 1708 |
|
|
2017
Q1 | $1.56M | Buy |
+35,240
| New | +$1.52M | ﹤0.01% | 2079 |
|
|
2015
Q2 | – | Sell |
-15,632
| Closed | -$468K | – | 2451 |
|
|
2015
Q1 | $468K | Buy |
15,632
+868
| +6% | +$27.6K | ﹤0.01% | 1999 |
|
|
2014
Q4 | $495K | Buy |
+14,764
| New | +$460K | ﹤0.01% | 2013 |
|
Other funds holding MED
SCP
VCM
Allianz Asset Management's MED Position: Q1 2026 in Review
Allianz Asset Management increased its Medifast (MED) stake by 13% in Q1 2026, buying an estimated $75.5K and bringing the position to 59,859 shares worth $610K. The position accounts for ﹤0.01% of the portfolio, ranked #1817.
Allianz Asset Management first reported a position in MED in Q4 2014 and has held it in 31 quarters since. The position peaked at $27.3M in Q2 2021. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.
- Allianz Asset Management held 59,859 shares of Medifast worth $610K as of Q1 2026.
- Allianz Asset Management bought 7,000 Medifast shares in Q1 2026, an estimated $75.5K.
- Medifast made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1817 holding.
- Allianz Asset Management first reported a position in Medifast in Q4 2014 and has held it in 31 quarters since.
- Allianz Asset Management's Medifast position peaked at $27.3M in Q2 2021.
- 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.